Stern S, Hodgkiss R J, Guichard M
Laboratoire de Radiobiologie Cellulaire, Institut Gustave Roussy, Villejuif, France.
Radiother Oncol. 1996 May;39(2):129-35. doi: 10.1016/0167-8140(96)01736-7.
The aim of this study was to compare the percentage of hypoxic cells obtained with two methods: an in vitro colony assay and a new method based on immunodetection of a marker for hypoxic cells (NITP) which could be used in patients. These studies have been carried out using one rodent tumour EMT6 (a mammary carcinoma) and one human tumour HRT18 (a rectal adenocarcinoma). The hypoxic cell fraction was assessed in control mice and in mice receiving two treatments: 250 mg/kg nicotinamide + carbogen, and 250 mg/kg nicotinamide + carbogen + 4 ml/kg perflubron emulsion. The two treatments increased the radiosensitivity of the two cell lines, nicotinamide plus carbogen plus perflubron emulsion having the greatest radiosensitising effect. For untreated and treated tumours, the percentage of hypoxic cells obtained with the in vitro colony assay were comparable to those obtained with immunodetection using NITP. Whatever the treatment, NITP detection was a convenient test to detect the hypoxic cell fraction in the two solid tumours we have studied.
一种是体外集落测定法,另一种是基于对缺氧细胞标志物(NITP)进行免疫检测的新方法,该方法可用于患者。这些研究使用了一种啮齿动物肿瘤EMT6(一种乳腺癌)和一种人类肿瘤HRT18(一种直肠腺癌)。在对照小鼠以及接受两种治疗的小鼠中评估缺氧细胞分数:250mg/kg烟酰胺+混合气,以及250mg/kg烟酰胺+混合气+4ml/kg全氟溴辛烷乳剂。这两种治疗方法提高了两种细胞系的放射敏感性,烟酰胺加混合气加全氟溴辛烷乳剂具有最大的放射增敏效果。对于未治疗和治疗后的肿瘤,通过体外集落测定法获得的缺氧细胞百分比与使用NITP进行免疫检测获得的百分比相当。无论采用何种治疗方法,NITP检测都是检测我们所研究的两种实体瘤中缺氧细胞分数的便捷测试。